Composition comprising mesenchymal stem cell aggregates wherein the D90 of said aggregates is less than 150 micomills

摘要

Disclosed are purified mesenchymal stem cell pharmaceutical compositions and methods of manufacture utilizing centrifugal filtration are disclosed. Threshold limits for intravenous administration of mesenchymal stem cell pharmaceutical compositions comprising residual animal products are also disclosed.